AstraZeneca Sues KV Pharma Over ANDA For Toprol-XL Generic

Law360, New York (September 19, 2004, 12:00 AM EDT) -- U.K-Swedish drug maker AstraZeneca has sued generic maker KV Pharmaceutical Company for patent infringement over its plans to launch a 50 mg generic version of hypertension drug Toprol-XL.

AstraZeneca said it sued KV Pharma in the U.S. District Court for the District of Delaware as a result of a Paragraph IV Certification letter concerning KV Pharma’s intent to manufacture and sell Toprol-XL (metoprolol succinate) in the 50 mg dose form in the U.S.

Generics drug applicants must include with their abbreviated new drug applications (ANDAs) a...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.